Role of hypoxia in cancer therapy by regulating the tumor microenvironment

By Xinming Jing, Fengming Yang, C. Shao, Ke Wei, M. Xie, Hua Shen, Yongqian Shu. Molecular Cancer, 2019

1,623 citations recorded by the source corpus.

Clinical resistance is a complex phenomenon in major human cancers involving multifactorial mechanisms, and hypoxia is one of the key components that affect the cellular expression program and lead to therapy resistance. The present study aimed to summarize the role of hypoxia in cancer therapy by regulating the tumor microenvironment (TME) and to highlight the potential of hypoxia-targeted therapy. Relevant published studies were retrieved from PubMed, Web of Science, and Embase using keywords such as hypoxia, cancer therapy, resistance, TME, cancer, apoptosis, DNA damage, autophagy, p53, and other similar terms. Recent studies have shown that hypoxia is associated with poor prognosis in patients by regulating the TME. It confers resistance to conventional therapies through a number of signaling pathways in apoptosis, autophagy, DNA damage, mitochondrial activity, p53, and drug efflux. Hypoxia targeting might be relevant to overcome hypoxia-associated resistance in cancer treatment.

Subfields: Biomedical Engineering, Cancer Research, Epidemiology

View Paper: https://www.semanticscholar.org/paper/69eed69f367514d73d052443dfa1494e54d9dead

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

  1. Sameer Quazi
  2. Tomasz M. Karpinski
  3. Shreelaxmi Gavas

In Cancer Research

  1. Sameer Quazi
  2. Tomasz M. Karpinski
  3. Shreelaxmi Gavas

In Epidemiology

  1. Sameer Quazi

Citations in the corpus